Benzinga | Jan 21, 2021 08:08AM EST

Aditx Therapeutics Announces AditxtScore Immune Monitoring Service Will Be Operational On February 1st

Mountain View, CA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the "Company") (NASDAQ:ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced the operational launch of the AditxtScore(tm) Immune Monitoring Platform as of February 1st, 2021.